INNOVATIVE RESEARCH
The institute provides a world-class interdisciplinary training environment for the preparation of technically skilled students who are capable of filling the diverse workforce needs in biomedical sciences. With key assets including centers for the study of inflammation, immunity and infection, microbial pathogenesis, oncology, molecular and cellular medicine, and diagnostics and therapeutics, the institute delivers both academic and research value to the field.
We've launched a new bachelor's degree program. The program prepares students for employment in the biomedical industry or advanced degrees in science, business or law. Learn More
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
More
Top Stories
Biomedical Sciences Researcher Gets $1.67 Million Federal Grant to Study Gut Immunity
Dr. Tim Denning, professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.67 million federal grant to study how an immunological pathway influences inflammatory signaling in the intestine that can lead to chronic human diseases such as inflammatory bowel disease.read more ❯
Researchers Develop Universal Flu Vaccine with Nanoparticles That Protects Against Six Different Influenza Viruses in Mice
A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine, according to a study by the Institute for Biomedical Sciences at Georgia State University.read more ❯
Researchers Develop Approach to Alter Intestinal Microbiota And Vaccinate Against Chronic Inflammatory Diseases
Targeted immunization against bacterial flagellin, a protein that forms the appendage that enables bacterial mobility, can beneficially alter the intestinal microbiota, decreasing the bacteria’s ability to cause inflammation and thus protecting against an array of chronic inflammatory diseases, according to a new study by the Institute for Biomedical Sciences and the Neuroscience Institute at Georgia State University.read more ❯